Editorial: Advances in Autoimmune Myasthenia Gravis

Editorial: Advances in Autoimmune Myasthenia Gravis

Bibliographic Details
Main Authors:	Anna Rostedt Punga, Linda Kusner, Sonia Berrih-Aknin, Rozen Le Panse
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-08-01
Series:	Frontiers in Immunology
Subjects:	autoantibodies CD4 T cells thymus therapy miRNA
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2020.01688/full

Similar Items

Advances in Autoimmune Myasthenia Gravis
Published: (2020)

Polymorphism of clinical phenotypes and heterogeneity of autoimmune targets of myasthenia gravis
by: Olena Klimova, et al.
Published: (2020-09-01)

Comparative Analysis of Thymic and Blood Treg in Myasthenia Gravis: Thymic Epithelial Cells Contribute to Thymic Immunoregulatory Defects
by: Frédérique Truffault, et al.
Published: (2020-05-01)

Autoimmune Thyroiditis and Myasthenia Gravis
by: Angela Lopomo, et al.
Published: (2017-07-01)

Decreased expression of miR-29 family associated with autoimmune myasthenia gravis
by: Mélanie A. Cron, et al.
Published: (2020-10-01)

The Muscle Is Not a Passive Target in Myasthenia Gravis
by: Jean-Thomas Vilquin, et al.
Published: (2019-12-01)

Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine
by: Liis Sabre, et al.
Published: (2020-03-01)

miR-146a in Myasthenia Gravis Thymus Bridges Innate Immunity With Autoimmunity and Is Linked to Therapeutic Effects of Corticosteroids
by: Federica Bortone, et al.
Published: (2020-03-01)

Role of miRNAs in Normal and Myasthenia Gravis Thymus
by: Mélanie A. Cron, et al.
Published: (2020-06-01)

The clinical outcome of thymectomy in myasthenia gravis
by: Mirsharifi R, et al.
Published: (2009-02-01)

Use of Toll-Like Receptor Agonists to Induce Ectopic Lymphoid Structures in Myasthenia Gravis Mouse Models
by: Marieke Robinet, et al.
Published: (2017-08-01)

The role of thymectomy in myasthenia gravis: A programmatic approach to thymectomy and perioperative management of myasthenia gravis
by: Ahmed AL-Bulushi, et al.
Published: (2021-06-01)

Epidemiology of Myasthenia Gravis in Sweden 2006–2016
by: Elisabet Westerberg, et al.
Published: (2020-11-01)

Multiple Thymoma with Myasthenia Gravis
by: Dong Hyun Seo, et al.
Published: (2017-02-01)

CIDP, myasthenia gravis, and membranous glomerulonephritis – three autoimmune disorders in one patient: a case report
by: Saskia Bolz, et al.
Published: (2018-08-01)

Characterization of thymic hyperplasia associated with autoimmune Myasthenia Gravis : role of the chemokines CXCL12 and CXCL13
by: Weiss, Julia Miriam
Published: (2011)

Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology
by: Miriam L. Fichtner, et al.
Published: (2020-05-01)

Management of Juvenile Myasthenia Gravis
by: Karen O'Connell, et al.
Published: (2020-07-01)

Myasthenia Gravis Related to Thymic Carcinoma: A Case Study
by: Daniel Thomas Pereira Lopes, et al.
Published: (2020-01-01)

Chapter Myasthenia Gravis: New Insights into the Effect of MuSK Antibodies and Acetylcholinesterase Inhibitors
by: Rostedt Punga, Anna
Published: (2011)

Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies
by: Hans Frykman, et al.
Published: (2020-12-01)

Selected Topics in Myasthenia Gravis
Published: (2019)

Lyme hastalığı ve myasthenia gravis
by: Ahmet EVLİCE, et al.
Published: (2018-12-01)

MuSK Antibody(+) Versus AChR Antibody(+) Myasthenia Gravis : Clinical, Neurophysiological and Morphological Aspects
by: Rostedt Punga, Anna
Published: (2007)

Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations
by: Laura Dresser, et al.
Published: (2021-05-01)

miRNA miR-21 Is Largely Dispensable for Intrathymic T-Cell Development
by: Heike Kunze-Schumacher, et al.
Published: (2018-11-01)

Myasthenia Gravis and Physical Exercise: A Novel Paradigm
by: Laura O'Connor, et al.
Published: (2020-07-01)

Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
by: Konstantinos Lazaridis, et al.
Published: (2020-11-01)

Impact of Different Thymic Pathologies on the Clinical Course of Myasthenia Gravis: A Population Wide Study in Latvia / Aizkrūts Dziedzera Patoloģiju Ietekmeu uz Myasthenia Gravis Klīnisko Gaitu: Populācijas Pētījums Latvijā
by: Zieda Anete, et al.
Published: (2015-09-01)

Myasthenia Gravis Can Have Consequences for Pregnancy and the Developing Child
by: Nils Erik Gilhus, et al.
Published: (2020-06-01)

Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics
by: Konstantinos Lazaridis, et al.
Published: (2020-02-01)

Causes and Consequences of miR-150-5p Dysregulation in Myasthenia Gravis
by: Mélanie A. Cron, et al.
Published: (2019-03-01)

MYASTHENIA GRAVIS AS A RISK FACTOR DURING PREGNANCY
by: A. A. Borshcheva, et al.
Published: (2018-05-01)

Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications
by: Kaori Noridomi, et al.
Published: (2017-04-01)

Clinical Characteristics of MuSK Antibody-positive Myasthenia Gravis in Taiwan
by: Yung-Chuan Huang, et al.
Published: (2008-07-01)

Botulinum toxin injections associated with suspected myasthenia gravis: An underappreciated cause of MG-like clinical presentation
by: Anna Rostedt Punga, et al.
Published: (2020-01-01)

Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs
by: Alyson A. Fiorillo, et al.
Published: (2020-02-01)

Medically resistant juvenile myasthenia gravis following thymectomy: Role for FDG PET/CT
by: Florence Ngu, et al.
Published: (2020-08-01)

Comment on “Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis”
by: Rozen Le Panse
Published: (2017-01-01)

Treatment of Autoimmune Myasthenia Gravis
by: J Gordon Millichap
Published: (2004-02-01)